Familial breast/ovarian cancer genotyping IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Familial breast/ovarian cancer genotyping IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 136076. The device is manufactured by Syantra Inc from Canada, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Medimap Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Familial breast/ovarian cancer genotyping IVD, kit, nucleic acid technique (NAT)

MHRA Device ID: 136076•Ref: 136076

Device Type

In Vitro Diagnostic Device

Devices

Familial breast/ovarian cancer genotyping IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Mar 23, 2024

Manufacturer Information

Name

Syantra Inc

Address

32 Royal Vista Drive NW Suite 105

Alberta, Calgary, Canada

Created Date

Feb 11, 2022

Authorized Representative

Name

Medimap Ltd

Relationship Type

UK Responsible Person

Address

2 The Drift

Thurston, Suffolk, United Kingdom

Postcode: IP31 3RT

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Same Authorized Representative (10)

Familial breast/ovarian cancer genotyping IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Clostridium difficile antigen IVD, kit, rapid ICT, clinical

Multiple Salmonella species immunoglobulin G (IgG)/IgM antibody IVD, kit, rapid ICT, clinical

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Carcinoembryonic antigen (CEA) IVD, kit, fluorescent immunoassay

Influenza A/B virus antigen IVD, kit, rapid ICT, clinical

Interleukin-6 (IL-6) IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

Prolactin IVD, kit, fluorescent immunoassay

B-type natriuretic protein/N-terminal pro b-type natriuretic peptide IVD, kit, rapid ICT, clinical

Barbiturate IVD, kit, rapid ICT, clinical

Barbiturate IVD, reagent

Benzodiazepine group IVD, reagent

Beta-haemolytic Group B Streptococcus antigen IVD, kit, rapid ICT, clinical

Buprenorphine IVD, kit, rapid ICT, clinical

C-reactive protein (CRP) IVD, kit, rapid ICT, clinical

Carcinoembryonic antigen (CEA) IVD, kit, rapid ICT, clinical

Clostridium difficile antigen IVD, kit, rapid ICT, clinical

Amphetamine-specific IVD, kit, rapid ICT, clinical